The chronic refractory cough market is witnessing robust expansion driven by increasing prevalence rates and unmet therapeutic needs. Innovations in targeted therapies and enhanced diagnostic protocols have fueled heightened interest, shaping the market dynamics profoundly. This blog presents a comprehensive chronic refractory cough market analysis encompassing market size, segments, consumer...

The clinical trial software industry is witnessing significant transformation driven by technological advancements and increased demand for streamlined drug development processes. With growing complexities in clinical trials and a focus on data integrity, this sector is poised for accelerated growth, aligned with dynamic market trends and emerging opportunities.Market Size and Overview The...

The global Abdominal Aortic Aneurysm (AAA) Treatment Market is expected to witness steady growth as healthcare providers increasingly adopt advanced surgical and minimally invasive endovascular procedures to treat abdominal aortic aneurysms. According to Future Market Insights (FMI), the market is projected to expand from USD 2.4 billion in 2026 to USD 4.1 billion by 2036, registering a CAGR of...

Transcranial stimulation devices are advanced non-invasive neuromodulation systems designed to stimulate targeted areas of the brain using controlled magnetic or electrical impulses. These technologies are increasingly used to manage a wide range of neurological and psychiatric conditions, including major depressive disorder, chronic pain, Parkinson's disease, stroke recovery, traumatic brain...

Transcranial stimulation devices are innovative, non-invasive brain stimulation technologies that use magnetic fields or gentle electrical currents to influence neural activity in specific regions of the brain. The primary types include Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS). These therapies are widely used to manage conditions...

The AI in Clinical Trials market is poised for significant transformation as artificial intelligence integrates deeper into the clinical development landscape, driving efficiency and accuracy. This industry is rapidly evolving through innovative applications of AI that optimize trial design, patient recruitment, and data analysis, shaping the future of clinical research with unprecedented scale...

According to Future Market Insights (FMI), The global ampoules packaging market is witnessing strong momentum as pharmaceutical manufacturers increasingly prioritize sterile, tamper-proof, and high-barrier packaging solutions for injectables, vaccines, and biologic therapies. Rising healthcare expenditure, expanding vaccine programs, and rapid growth in biologics are significantly increasing...

The global amyloidosis treatment market is poised for strong growth as healthcare systems increasingly prioritize rare disease management, precision medicine, and advanced therapeutic interventions. Valued at USD 6.2 billion in 2025, the market is projected to reach USD 12.9 billion by 2035, growing at a 7.5% CAGR during the forecast period. Growth is increasingly driven by therapeutic...

NEWARK, Del., July 11, 2026 — The global Healthcare Antibody Quantification Market is expected to witness robust growth as biologics development, immunology research, and precision diagnostics continue expanding across pharmaceutical and biotechnology industries. According to Future Market Insights (FMI), the market is projected to grow from USD 7.8 billion in 2026 to USD 17.0 billion by...

Vagus nerve stimulation (VNS) devices are advanced therapeutic medical devices that deliver gentle electrical impulses to the vagus nerve to modulate neural activity and improve communication between the brain and the body. They are primarily used to manage neurological and psychiatric conditions such as drug-resistant epilepsy, treatment-resistant depression, chronic pain, migraines, stroke...

Vagus nerve stimulation (VNS) devices are innovative neuromodulation systems that deliver controlled electrical pulses to the vagus nerve to help regulate brain function and support communication within the nervous system. These devices are used to treat various neurological and psychiatric disorders, including drug-resistant epilepsy, treatment-resistant depression, chronic migraines,...

Vagus nerve stimulation (VNS) devices are specialized neuromodulation systems that deliver gentle electrical impulses to the vagus nerve to regulate abnormal nerve activity and enhance communication between the brain and the body's organs. This therapy is designed to improve neurological function and provide long-term symptom relief for patients with chronic neurological and psychiatric...

Deep brain stimulation (DBS) devices are implantable neuromodulation technologies designed to treat neurological disorders by delivering precisely controlled electrical impulses to targeted areas of the brain. These impulses help normalize abnormal neural activity, providing symptom relief for patients with conditions such as Parkinson's disease, essential tremor, dystonia, epilepsy, and...

Deep Brain Stimulation (DBS) devices are implantable neurostimulation systems that use carefully controlled electrical impulses to stimulate targeted areas of the brain. This therapy helps regulate abnormal brain signals associated with movement disorders and certain neurological or psychiatric conditions, providing symptom relief for patients who do not respond adequately to medication. DBS is...

Deep Brain Stimulation (DBS) devices are implantable neurostimulation systems that use carefully controlled electrical impulses to stimulate targeted areas of the brain. This therapy helps regulate abnormal brain signals associated with movement disorders and certain neurological or psychiatric conditions, providing symptom relief for patients who do not respond adequately to medication. DBS is...

The global Brain PET-MRI Systems Market is expanding as hospitals, neurological centers, and research institutions increasingly adopt hybrid imaging technologies that combine molecular information from positron emission tomography (PET) with detailed anatomical imaging from magnetic resonance imaging (MRI). According to Future Market Insights (FMI), the market is projected to grow from USD...

In an era defined by rising health consciousness and a global shift toward preventive wellness, bromelain supplements have emerged as one of the most compelling natural enzyme-based health products on the market. Derived from the pineapple plant (Ananas comosus), bromelain is a proteolytic enzyme with a remarkable range of biological activities that translate into tangible health benefits for...

According to the latest report published by Data Bridge Market Research, the Liver Fibrosis Interleukin (Il) Inhibitors Market  CAGR Value The global liver fibrosis interleukin (Il) inhibitors market was valued at USD 776.62 million in 2024 and is expected to reach USD 1738.80 million by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...

The global cancer cachexia market is witnessing steady growth as the increasing prevalence of cancer fuels the demand for supportive therapies that improve patients' quality of life. Cancer cachexia, a multifactorial syndrome characterized by severe weight loss, muscle wasting, and metabolic abnormalities, remains one of the most challenging complications in oncology care. Growing investments...

Market Overview According to MarketGenics, the global Immunotherapy Market is valued at USD 244.1 billion in 2025 and is projected to reach USD 564.3 billion by 2035, registering a CAGR of 8.7% during the forecast period. The market is experiencing robust growth due to the increasing adoption of immunotherapy as a preferred treatment option for cancer, autoimmune disorders, infectious diseases,...